## KMI: Kinder Morgan, Inc. - XLE: Energy

### Executive Summary

No thesis match: MRS_20 -1.3% below STRENGTH zone (4.0-10.0%); PEG 2.11 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge.

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($26.23)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 9
- **Sentiment:** Neutral (Bullish: 0, Bearish: 0)

**1. Amundi Sells 2,950,260 Shares of Kinder Morgan, Inc. $KMI**
- Source: MarketBeat | 20251206T083751 | Neutral | Relevance: 97%
-  Amundi reduced its stake in Kinder Morgan, Inc. (NYSE:KMI) by 23.1% in the second quarter, selling over 2.95 million shares, though it still owns 9.81 million shares valued at $279.6 million. Despite this, other institutional investors have either acquired new positions or increased their holdings in the company. Chairman Richard D. Kinder and Director Amy W. Chronis also made significant purchases of company stock in October, indicating insider confidence.

**2. Fluor JV Finishes Second LNG Train at Canadaâ€™s First Mega-Export Terminal**
- Source: Pipeline and Gas Journal | 20251208T150931 | Somewhat-Bullish | Relevance: 64%
- Fluor Corporation and JGC Corporation have completed Train 2 of the LNG Canada Project in Kitimat, British Columbia, marking a significant milestone for Canada's largest LNG export facility. The project, valued at $40 billion, aims to export up to 14 million tonnes of LNG annually and has significantly contributed to local and Indigenous economies. This completion positions Canada as a new LNG exporter to Asian markets, addressing growing global demand.

**3. Winslow Capital Management LLC Grows Stock Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251208T132524 | Neutral | Relevance: 63%
-  Winslow Capital Management LLC increased its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 20.2% in Q2, making it their 13th largest holding. Despite this institutional accumulation, company insiders, including CEO Gary S. Guthart and EVP Henry L. Charlton, sold significant portions of their shares, totaling approximately $60.8 million. Intuitive Surgical recently surpassed Q3 earnings and revenue expectations, and the stock currently holds a "Moderate Buy" consensus rating from analysts with a target price of $607.17.

**4. Marshall Wace LLP Has $79.30 Million Position in Intuitive Surgical, Inc. $ISRG**
- Source: MarketBeat | 20251206T110804 | Neutral | Relevance: 62%
-  Marshall Wace LLP significantly increased its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 78% in Q2, bringing its stake to $79.30 million. Wall Street analysts maintain a largely bullish outlook on ISRG, with a "Moderate Buy" consensus and an average price target of $607.17. Despite insider selling totaling approximately $60.76 million recently, institutional investors collectively own 83.64% of the company's stock.

**5. Intuitive Surgical (NASDAQ:ISRG) Downgraded to "Hold" Rating by Wall Street Zen**
- Source: MarketBeat | 20251206T081048 | Neutral | Relevance: 62%
- Wall Street Zen has downgraded Intuitive Surgical (NASDAQ:ISRG) to a "Hold" rating from "Buy." Despite this downgrade, the stock still holds a "Moderate Buy" consensus from other analysts with a target price of $607.17, while trading near $575. Noteworthy insider selling has occurred, with Gary Guthart selling 22,806 shares for approximately $13.0M, and total insider sales amounting to about 108,939 shares ($60.8M) in the last 90 days.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 2, Lowers: 1)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-14 | Mizuho | $31 | $32 | -3% |
| 2025-11-13 | RBC Capital | $30 | $28 | +7% |
| 2025-11-11 | Stifel | $30 | $29 | +3% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-14 | Mizuho | main | Outperform |
| 2025-11-13 | RBC Capital | main | Sector Perform |
| 2025-11-11 | Stifel | main | Hold |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_BUYING** |
| Buys | 3 ($26.08M) |
| Sells | 4 ($1.00M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 33.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 6 / 3 |

**Top Holders:**
- Vanguard Group Inc: 9.3% (+0.4%)
- Blackrock Inc.: 7.9% (+6.0%)
- State Street Corpora: 5.1% (-0.5%)
- JPMORGAN CHASE & CO: 2.9% (+83.5%)
- Geode Capital Manage: 2.4% (+2.1%)

### Key Risks

1. Market regime shift could impact momentum names disproportionately.
2. Sector rotation risk if leadership changes from current market theme.
3. Earnings execution risk on next quarterly report.

### Catalysts

- AI/machine learning initiatives could drive multiple expansion if executed.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 2.11 elevated, pricing in significant growth expectations. Forward P/E 19.9x stretched relative to 7% growth. Quality metrics strong (margin 17%). Analyst sentiment positive (2 raises, avg +5%). Insider buying signal ($26.1M), management confidence. Institutional flow bullish (6 buying vs 3 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $60.7B |
| Beta | 0.67 |
| 52W Range | $23.94 - $31.48 |
| Short Interest | 2.2% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 2.11 |
| Forward P/E | 19.9 |
| Current P/E | 21.2 |
| YoY Growth | 6.8% |
| EPS Direction | STABLE |

### Technicals

MRS_20 stable at -1.3% (minimal 5-day change). Below STRENGTH zone by 5.3pp (needs >4.0% for momentum thesis). Below SMA200 (1.00x), long-term trend not supportive. RSI neutral at 53.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -1.32% (CS: 46) | Neutral |
| RSI_14 | 53.1 | Neutral |
| MACD Histogram | 0.08 | Bullish |
| vs SMA20 | 1.007x | Above |
| vs SMA50 | 1.007x | Above |
| vs SMA200 | 1.000x | Below |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $27.29
- **Stop Loss:** $26.23 (3.9% risk)
- **Target:** $28.35 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 471
- **Position Value:** $12,853.59
- **Portfolio %:** 12.85%
- **Risk Dollars:** $500.00
- **Risk Per Trade:** 0.50%
- **Modifiers:** L1 100% | L2 50% | Combined 0.50x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.00x |
| L2 Sector | AVOID (Zone C) | 0.50x |

### Earnings

**Next:** 2026-01-21 (Est: $0.37)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.30 | $0.29 | -2.8% |
| 2025Q2 | $0.28 | $0.28 | +0.8% |
| 2025Q1 | $0.36 | $0.34 | -4.8% |
| 2024Q4 | $0.33 | $0.32 | -2.7% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*